Inventor · disambiguated record
Cornelia Adriana Maria Heinz
Also filed as: HEINZ CORNELIA · HEINZ CORNELIA ADRIANA MARIA
8 granted patents·4 pending applications·27 citations·filing 2013–2024
84Inventor score
Top patents by PatentIndex Score
12 records- 0191US10813996B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2018·Granted Oct 27, 2020·4 cites·18 claims
- 0290US9770487B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinomaGANYMED PHARMACEUTICALS AG·Filed 2014·Granted Sep 26, 2017·11 cites·30 claims
- 0388US10314890B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancerGANYMED PHARMACEUTICALS AG·Filed 2017·Granted Jun 11, 2019·5 cites·40 claims
- 0485US2024335533A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2024·Application pending·0 cites
- 0583US9433675B2Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2013·Granted Sep 6, 2016·5 cites·23 claims
- 0681US2024091312A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2023·Application pending·0 cites
- 0779US10022444B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2016·Granted Jul 17, 2018·2 cites·32 claims
- 0873US11826402B2Combination therapy involving antibodies against claudin 18.2 for treatment of metastatic pancreatic adenocarcinomaASTELLAS PHARMA INC·Filed 2020·Granted Nov 28, 2023·0 cites·7 claims
- 0972US12059464B2Combination therapy involving antibodies against Claudin 18.2 for treatment of cancerASTELLAS PHARMA INC·Filed 2020·Granted Aug 13, 2024·0 cites·22 claims
- 1071US10946069B2Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancerASTELLAS PHARMA INC·Filed 2019·Granted Mar 16, 2021·0 cites·20 claims
- 1149US2015132253A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2013·Application pending·0 cites
- 1248US2018258180A1Combination therapy involving antibodies against claudin 18.2 for treatment of cancerGANYMED PHARMACEUTICALS AG·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →